BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24932473)

  • 1. Depletion of the aryl hydrocarbon receptor in MDA-MB-231 human breast cancer cells altered the expression of genes in key regulatory pathways of cancer.
    Goode G; Pratap S; Eltom SE
    PLoS One; 2014; 9(6):e100103. PubMed ID: 24932473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line.
    Goode GD; Ballard BR; Manning HC; Freeman ML; Kang Y; Eltom SE
    Int J Cancer; 2013 Dec; 133(12):2769-80. PubMed ID: 23733406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
    Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
    BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.
    Tomblin JK; Arthur S; Primerano DA; Chaudhry AR; Fan J; Denvir J; Salisbury TB
    Biochem Pharmacol; 2016 Apr; 106():94-103. PubMed ID: 26944194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-(4-Hydroxy-3-methoxyphenyl)-benzothiazole suppresses tumor progression and metastatic potential of breast cancer cells by inducing ubiquitin ligase CHIP.
    Hiyoshi H; Goto N; Tsuchiya M; Iida K; Nakajima Y; Hirata N; Kanda Y; Nagasawa K; Yanagisawa J
    Sci Rep; 2014 Nov; 4():7095. PubMed ID: 25403352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.
    Novikov O; Wang Z; Stanford EA; Parks AJ; Ramirez-Cardenas A; Landesman E; Laklouk I; Sarita-Reyes C; Gusenleitner D; Li A; Monti S; Manteiga S; Lee K; Sherr DH
    Mol Pharmacol; 2016 Nov; 90(5):674-688. PubMed ID: 27573671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis.
    Jin UH; Lee SO; Pfent C; Safe S
    BMC Cancer; 2014 Jul; 14():498. PubMed ID: 25011475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AhR ligands reactivate LINE-1 retrotransposon in triple-negative breast cancer cells MDA-MB-231 and non-tumorigenic mammary epithelial cells NMuMG.
    Miret N; Zappia CD; Altamirano G; Pontillo C; Zárate L; Gómez A; Lasagna M; Cocca C; Kass L; Monczor F; Randi A
    Biochem Pharmacol; 2020 May; 175():113904. PubMed ID: 32156659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Expression Profiling Identifies Cell Proliferation and Inflammation as the Predominant Pathways Regulated by Aryl Hydrocarbon Receptor in Primary Human Fetal Lung Cells Exposed to Hyperoxia.
    Shivanna B; Maity S; Zhang S; Patel A; Jiang W; Wang L; Welty SE; Belmont J; Coarfa C; Moorthy B
    Toxicol Sci; 2016 Jul; 152(1):155-68. PubMed ID: 27103661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.
    Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W
    PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted salmon gene array (SalArray): a toxicogenomic tool for gene expression profiling of interactions between estrogen and aryl hydrocarbon receptor signalling pathways.
    Mortensen AS; Arukwe A
    Chem Res Toxicol; 2007 Mar; 20(3):474-88. PubMed ID: 17291011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptor.
    Brooks J; Eltom SE
    Curr Cancer Drug Targets; 2011 Jun; 11(5):654-69. PubMed ID: 21486221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor counteracts pharmacological efficacy of doxorubicin via enhanced AKR1C3 expression in triple negative breast cancer cells.
    Yamashita N; Kanno Y; Saito N; Terai K; Sanada N; Kizu R; Hiruta N; Park Y; Bujo H; Nemoto K
    Biochem Biophys Res Commun; 2019 Aug; 516(3):693-698. PubMed ID: 31253396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
    Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
    Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.
    Hall JM; Barhoover MA; Kazmin D; McDonnell DP; Greenlee WF; Thomas RS
    Mol Endocrinol; 2010 Feb; 24(2):359-69. PubMed ID: 20032195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.
    Stanford EA; Wang Z; Novikov O; Mulas F; Landesman-Bollag E; Monti S; Smith BW; Seldin DC; Murphy GJ; Sherr DH
    BMC Biol; 2016 Mar; 14():20. PubMed ID: 26984638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
    Wihlén B; Ahmed S; Inzunza J; Matthews J
    Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.
    Vacher S; Castagnet P; Chemlali W; Lallemand F; Meseure D; Pocard M; Bieche I; Perrot-Applanat M
    PLoS One; 2018; 13(1):e0190619. PubMed ID: 29320557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.
    Mehner C; Hockla A; Miller E; Ran S; Radisky DC; Radisky ES
    Oncotarget; 2014 May; 5(9):2736-49. PubMed ID: 24811362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling in triple negative breast cancer is associated with metastasis.
    Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
    BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.